These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33167572)

  • 1. Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia.
    Bernabeu C; Bayrak-Toydemir P; McDonald J; Letarte M
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33167572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).
    Whitehead KJ; Toydemir D; Wooderchak-Donahue W; Oakley GM; McRae B; Putnam A; McDonald J; Bayrak-Toydemir P
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.
    Ardelean DS; Letarte M
    Front Genet; 2015; 6():35. PubMed ID: 25717337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.
    DeBose-Scarlett E; Ressler AK; Gallione CJ; Sapisochin Cantis G; Friday C; Weinsheimer S; Schimmel K; Spiekerkoetter E; Kim H; Gossage JR; Faughnan ME; Marchuk DA
    Am J Hum Genet; 2024 Oct; 111(10):2283-2298. PubMed ID: 39299239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
    Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms.
    Drapé E; Anquetil T; Larrivée B; Dubrac A
    Front Hum Neurosci; 2022; 16():1006115. PubMed ID: 36504622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
    Snellings DA; Gallione CJ; Clark DS; Vozoris NT; Faughnan ME; Marchuk DA
    Am J Hum Genet; 2019 Nov; 105(5):894-906. PubMed ID: 31630786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms.
    Arthur HM; Roman BL
    Front Med (Lausanne); 2022; 9():973964. PubMed ID: 36250069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
    Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
    Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Expression of Circulating Plasma miRNA-370 and miRNA-10a from Patients with Hereditary Hemorrhagic Telangiectasia.
    Ruiz-Llorente L; Albiñana V; Botella LM; Bernabeu C
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
    Gamboa NT; Joyce EJ; Eli I; Park MS; Taussky P; Schmidt RH; McDonald J; Whitehead KJ; Kalani MYS
    J Clin Neurosci; 2018 May; 51():22-28. PubMed ID: 29483005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
    Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
    Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
    Tillet E; Bailly S
    Front Genet; 2014; 5():456. PubMed ID: 25620979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.